Health Net
Pomalyst (pomalidomide)
Drugs for Cancer : Drugs for Cancer
  • Anti-Cancer:Maximum $200 copayment per State Law. Must use AcariaHlth SP pharmacy SF Split Fill
  • Prior Authorization: Multiple Myeloma:
    Documented Diagnosis: Yes
    Age Requirement: >= 18
    Duration: 1 plan year
    Reauthorization Required: Yes

  • Multiple Myeloma:
    Age Requirement: >= 18
    Duration: 1 plan year
    Specialist Required: Yes
    Documented Diagnosis: Yes
    Medical Test Required: No
    Specialist Type(s): 1 of Hematologist;Oncologist
    Reauthorization Required: Yes
    Duration of Reauthorization: = 1 plan year
    Drug Policy Based On: 1 of FDA Approved Indications;NCCN Guidelines
    ECOG Score Requirement in Policy: N/A
    ECOG status <=2: No
    Diagnosis Types: 1 of All FDA-approved indications;All NCCN indications with evidence level of 2A or higher;in combination with dexamethasone after at least two prior therapies including lenalidomide and a proteasome inhibitor and demonstrated disease progression on or within 60 days of completion of the last therapy;Patients who have received at least 2 prior regimens including a PI and an immunomodulatory agent
    Concomitant Therapy Requirement: in combination with dexamethasone